• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to 3-({(tert-butoxy)carbonylamino}methyl)pentanoic Acid (CAS No. 1520638-84-9)

3-({(tert-butoxy)carbonylamino}methyl)pentanoic acid, with the chemical formula C₁₁H₂₁NO₄, is a significant compound in the field of pharmaceutical chemistry and bioconjugation. This compound, identified by its CAS number CAS No. 1520638-84-9, has garnered attention due to its versatile applications in drug development and synthetic biology. The structure of this molecule features a pentanoic acid backbone modified with a (tert-butoxy)carbonylamino side chain, which enhances its reactivity and utility in various chemical transformations.

The (tert-butoxy)carbonylamino group is particularly noteworthy as it serves as a protective group for amino functions in peptide synthesis and as a linker in the development of bioconjugates. This feature makes 3-({(tert-butoxy)carbonylamino}methyl)pentanoic acid a valuable intermediate in the synthesis of more complex molecules, including peptidomimetics and protein-drug conjugates. The pentanoic acid moiety provides a flexible alkyl chain that can be further functionalized, allowing for the creation of diverse pharmacophores.

In recent years, there has been growing interest in the development of novel bioconjugates for therapeutic applications. These conjugates often require precise molecular design to achieve optimal pharmacokinetic and pharmacodynamic properties. The use of 3-({(tert-butoxy)carbonylamino}methyl)pentanoic acid as a building block has enabled researchers to create novel compounds with enhanced stability and targeted delivery systems. For instance, its incorporation into antibody-drug conjugates (ADCs) has shown promise in preclinical studies for the treatment of various cancers.

The protective nature of the (tert-butoxy)carbonylamino group is particularly advantageous in multi-step synthetic routes where selective protection and deprotection are required. This functionality allows for controlled modifications without unintended side reactions, ensuring high yields and purity of the final product. The versatility of this compound has made it a staple in synthetic organic chemistry labs focused on pharmaceutical research.

Recent advancements in mass spectrometry and NMR spectroscopy have further facilitated the study of 3-({(tert-butoxy)carbonylamino}methyl)pentanoic acid and its derivatives. These techniques have enabled detailed structural elucidation and kinetic studies, providing insights into reaction mechanisms and optimization strategies. Such methodologies are crucial for understanding how this compound behaves in different chemical environments, which is essential for its effective utilization in drug development.

The application of computational chemistry has also played a significant role in the study of this compound. Molecular modeling and docking studies have been employed to predict binding interactions with biological targets, aiding in the design of more effective therapeutic agents. These computational approaches complement experimental work by providing rapid screening of potential candidates and helping to refine synthetic strategies.

In summary, 3-({(tert-butoxy)carbonylamino}methyl)pentanoic acid (CAS No. 1520638-84-9) is a multifaceted compound with broad applications in pharmaceutical chemistry. Its unique structure, featuring both a protective group and a flexible alkyl chain, makes it an invaluable tool for the synthesis of complex bioconjugates. The ongoing research into its applications continues to uncover new possibilities for its use in drug development and synthetic biology, solidifying its importance as a key intermediate in modern medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)